Caribou Biosciences, Inc. has initiated the dose expansion portion of the CB-010 ANTLER phase 1 trial in second-line patients with large B cell lymphoma (LBCL) following the completion of the dose escalation portion of the trial.
AI Assistant
CARIBOU BIOSCIENCES INC
2023
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.